VAM Funds, the specialist investment boutique, has gained FSA approval, under UCITS III regulation, to market its Luxembourg-domiciled VAM Funds (Lux) range in the UK. The development will assist the company’s expansion in the UK retail market.
Eight funds have gained approval from the FSA. They include: VAM US Micro Cap Growth Fund; VAM US Small Cap Growth Fund; VAM US Mid Cap Fund; VAM US Large Cap Growth Fund; VAM Emerging Markets Growth Fund; VAM International Real Estate Fund; VAM World Growth Fund; VAM Asia Fixed Income Fund. Seven of the funds are managed by Driehaus Capital Management LLC. The VAM Asia Fixed Income Fund is managed by Enhanced Investment Products (EIP) in Hong Kong.
Michael Hunt, Managing Director of VAM Funds, says: “The move into the UK market is an important milestone in the development of VAM Funds as a global business. The UK has set the standard in fund regulation and expertise. FSA approval represents and an important affirmation of the quality of the VAM Funds (Lux) offering.”
Nigel Watson, Global Sales Director of VAM Funds, says: “The high level of interest from the investment community in the UK leads us to believe that our biggest opportunity for growth in 2010 is here. The VAM Funds range offers something out of the ordinary – access to world class fund managers usually only available to financial institutions or the wealthiest individuals.
“The VAM fund range will be available to UK investors predominantly through personal portfolio bonds, platforms and discretionary managers. We have recently recruited Andrew Janes and Dean Currie as Business Development Managers and we are confident their experience and knowledge will help drive us to reach, and exceed, our targets.”
';